RPRX is Royalty Pharma PLC (Healthcare). Trading at $54.50. Current dividend yield: 1.72%.
Dividend snapshot
| Annual dividend rate | $0.94 |
| Current yield | 1.72% |
| Payment frequency | Quarterly |
| Next ex-dividend date | May 15, 2026 |
| Most recent payment date | Jun 10, 2026 |
| Last payment amount | $0.2350 |
| 5-year dividend CAGR | 24.01% |
| 3-year dividend CAGR | 5.01% |
| Payout ratio | 47% |
| Market cap | $31.38B |
| Exchange | NMS |
Recent dividend payments
| Date | Amount / share |
|---|---|
| 2026-05-15 | $0.2350 |
| 2026-02-20 | $0.2350 |
| 2025-11-14 | $0.2200 |
| 2025-08-15 | $0.2200 |
| 2025-05-16 | $0.2200 |
| 2025-02-21 | $0.2200 |
| 2024-11-15 | $0.2100 |
| 2024-08-16 | $0.2100 |
About RPRX
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Track RPRX in DiviDrip
Add RPRX to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.
- Open DiviDrip — search RPRX and add your shares.
- View the RPRX Dividend Triangle — see Revenue × EPS × Dividend growth at a glance.
- Stock Screener — find more dividend payers like RPRX.
- DiviDrip Learn — free guides on DRIP, dividend tiers, ETF comparisons.
Data refreshed 2026-05-24. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.